Registered entities
Axikin Pharmaceuticals, Inc.
Reg. No. 26-2664687United States
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
US-based, clinical-stage biopharma developing chemokine receptor targeting small molecules for respiratory, inflammatory and autoimmune diseases
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |